Michael D. Devous

21.4k total citations · 2 hit papers
203 papers, 8.8k citations indexed

About

Michael D. Devous is a scholar working on Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Michael D. Devous has authored 203 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Radiology, Nuclear Medicine and Imaging, 59 papers in Psychiatry and Mental health and 50 papers in Cognitive Neuroscience. Recurrent topics in Michael D. Devous's work include Medical Imaging Techniques and Applications (45 papers), Dementia and Cognitive Impairment Research (44 papers) and Alzheimer's disease research and treatments (41 papers). Michael D. Devous is often cited by papers focused on Medical Imaging Techniques and Applications (45 papers), Dementia and Cognitive Impairment Research (44 papers) and Alzheimer's disease research and treatments (41 papers). Michael D. Devous collaborates with scholars based in United States, Netherlands and Canada. Michael D. Devous's co-authors include Frederick J. Bonte, Michael J. Pontecorvo, Ramon Diaz‐Arrastia, Mark A. Mintun, Abhinay D. Joshi, Michael Navitsky, Christopher C. Rowe, Karen M. Rodrigue, Kristen M. Kennedy and Jenny Rieck and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Circulation Research.

In The Last Decade

Michael D. Devous

199 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

2014 690 citations Michael D. Devous, Michael J. Pontecorvo et al. Alzheimer s & Dementia profile →
Four distinct trajectories of tau deposition identified in Alzheimer’s disease

2021 400 citations Jacob W. Vogel, Alexandra L. Young et al. Nature Medicine profile →

Peers

Countries citing papers authored by Michael D. Devous

Since Specialization

Citations

This map shows the geographic impact of Michael D. Devous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Devous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Devous more than expected).

Fields of papers citing papers by Michael D. Devous

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Devous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Devous. The network helps show where Michael D. Devous may publish in the future.

Co-authorship network of co-authors of Michael D. Devous

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Devous. A scholar is included among the top collaborators of Michael D. Devous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Devous. Michael D. Devous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression 2023 ·Alzheimer s Research & Therapy ·(unknown), Sudeepti Southekal, Michael Navitsky, Ian Kennedy, Ming‐Chi Lu, Amanda Sheffield Morris, Jennifer A. Zimmer, Adam Fleisher, Mark A. Mintun, Michael D. Devous, Michael J. Pontecorvo	11
2	Four distinct trajectories of tau deposition identified in Alzheimer’s disease breakdown → 2021 ·Nature Medicine ·(unknown), Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, Ruben Smith, Rik Ossenkoppele, Olof Strandberg, Renaud La Joie, Leon Aksman, Michel J. Grothe, Yasser Iturria‐Medina, Michael J. Pontecorvo, Michael D. Devous, Gil D. Rabinovici, Daniel C. Alexander, Chul Hyoung Lyoo, Alan C. Evans, Oskar Hansson	400
3	¹²³ I-Iofluopane Single-Photon Emission Computed Tomography as an Imaging Biomarker of Pre-Synaptic Dopaminergic System after Moderate-to-Severe Traumatic Brain Injury 2020 ·Journal of Neurotrauma ·Kyle Womack, (unknown), Librada Callender, (unknown), Marie N. Dahdah, Thomas S. Harris, Michael D. Devous, Shannon B. Juengst, Kathleen Bell, Ramon Diaz‐Arrastia, Kan Ding	4
4	IC‐P‐216: LOBAR CLASSIFICATION OF TAU PET IMAGES IN THE EXPEDITION‐3 TRIAL 2018 ·Alzheimer s & Dementia ·Sergey Shcherbinin, Peng Liu, Adam Fleisher, Karen Sundell, Arnaud Charil, Ming‐Chi Lu, Michael D. Devous, Michael J. Pontecorvo, Mark A. Mintun, Eric Siemers, Michael C. Irizarry, Adam J. Schwarz	1
5	Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity 2017 ·Journal of Nuclear Medicine ·Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming‐Chi Lu, Abhinay D. Joshi, Michael J. Pontecorvo, Mark A. Mintun	58
6	Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18 2017 ·Journal of Nuclear Medicine ·Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, (unknown), Ming‐Chi Lu, William R. Shankle, John Seibyl, Kenneth Marek, Mark A. Mintun	52
7	Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition 2017 ·Brain ·Michael J. Pontecorvo, Michael D. Devous, Michael Navitsky, Ming‐Chi Lu, Stephen Salloway, Frederick W. Schaerf, Danna Jennings, Anupa Arora, Anne McGeehan, Nathaniel C. Lim, Hui Xiong, Abhinay D. Joshi, Andrew Siderowf, Mark A. Mintun, (unknown)	263
8	Kinetics of the Tau PET Tracer ¹⁸F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease 2016 ·Journal of Nuclear Medicine ·Sergey Shcherbinin, Adam J. Schwarz, Abhinay D. Joshi, Michael Navitsky, Matthew Flitter, William R. Shankle, Michael D. Devous, Mark A. Mintun	80
9	Successful classification of cocaine dependence using brain imaging: a generalizable machine learning approach 2016 ·BMC Bioinformatics ·Mutlu Mete, Ünal Sakoğlu, Jeffrey S. Spence, Michael D. Devous, Thomas S. Harris, Bryon Adinoff	33
10	Cortico-Amygdala Coupling as a Marker of Early Relapse Risk in Cocaine-Addicted Individuals 2014 ·Frontiers in Psychiatry ·Meredith McHugh, Catherine H. Demers, Betty Jo Salmeron, Michael D. Devous, Elliot A. Stein, Bryon Adinoff	62
11	A comprehensive reliability assessment of quantitative diffusion tensor tractography 2011 ·NeuroImage ·Jun Yi Wang, Hervé Abdi, Khamid Bakhadirov, Ramon Diaz‐Arrastia, Michael D. Devous	106
12	Assessing Spatial Relationships between Axonal Integrity, Regional Brain Volumes, and Neuropsychological Outcomes after Traumatic Axonal Injury 2010 ·Journal of Neurotrauma ·Matthew A. Warner, Carlos Marquez de la Plata, Jeffrey S. Spence, Jun Yi Wang, Caryn R. Harper, Carol Moore, Michael D. Devous, Ramon Diaz‐Arrastia	106
13	Procedure Guideline for Brain Perfusion SPECT Using 99mTc Radiopharmaceuticals 3.0 2009 ·Journal of Nuclear Medicine Technology ·Jack E. Juni, (unknown), Michael D. Devous, Ronald S. Tikofsky, Masanori Ichise, Ronald L. Van Heertum, Renzo Carretta, (unknown)	58
14	Single-photon emission computed tomography in neurotherapeutics 2005 ·PubMed ·Michael D. Devous	31
15	Dose-response measures of rCBF and subjective changes following procaine in healthy female volunteers 2002 ·Psychiatry Research Neuroimaging ·Bryon Adinoff, Michael D. Devous, Susan E. Best, (unknown), Jerri Payne, Mark Williams	6
16	Cerebellar blood flow in schizophrenic patients and normal control subjects 1995 ·Psychiatry Research Neuroimaging ·Joel L. Steinberg, Michael D. Devous, F. Gerard Moeller, Ronald G. Paulman, Joachim D. Raese, (unknown)	21
17	Regional cerebral blood flow alterations in unipolar depression 1993 ·Psychiatry Research Neuroimaging ·Michael D. Devous, Christina M. Gullion, Bruce D. Grannemann, Madhukar H. Trivedi, A. John Rush	25
18	The Effect of Acetazolamide on Regional Cerebral Blood Flow in Patients with Alzheimer??s Disease or Stroke as Measured by Single-Photon Emission Computed Tomography 1989 ·Investigative Radiology ·Frederick J. Bonte, Michael D. Devous, Joan Reisch, Ajay Ajmani, Myron Weiner, Jim Hom, Ron Tintner	32
19	A long-term follow-up case study of crossed aphasia assessed by single-photon emission tomography (SPECT), language, and neuropsychological testing 1988 ·Brain and Language ·Delaina Walker-Batson, John S. Wendt, Michael D. Devous, (unknown), Frederick J. Bonte	17
20	Scintigraphic evaluation of equine lameness. 1980 ·Proceedings of the ... Annual Convention - American Association of Equine Practitioners. ·(unknown), Michael D. Devous	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact